REGN News | Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc (REGN)

616.99

-1.12 (-0.18%) USD | NASDAQ | Jan 20, 14:50

News

Headline

Wire

Time (ET)

Leavell Investment Management, Inc. Buys Quadratic Interest Rate Volatility And Inflation H, ...

Yahoo

01/20 13:38

Forty Accomplished Young Scientists Named Finalists in the 2022 Regeneron Science Talent Search

PR Newswire

01/20 12:00

Regeneron (REGN)/Sanofi's Libtayo sBLA Accepted by the FDA

Yahoo

01/20 10:41

Gamida (GMDA) Up on Omidubicel BLA Rolling Submission Plan

Yahoo

01/20 10:39

Sanofi (SNY) 2nd Dupixent Prurigo Nodularis Study Meets Goal

Yahoo

01/20 10:35

Archford Capital Strategies, LLC Buys iShares Short Treasury Bond ETF, Global X Autonomous ...

Yahoo

01/20 09:38

Monarch Capital Management Inc Buys Fiserv Inc, Lockheed Martin Corp, Regeneron Pharmaceuticals ...

Yahoo

01/19 21:38

Sanofi-Regeneron's Libtayo combo accepted for review by FDA for lung cancer subtype

SA Breaking News

01/19 11:52

Will 2022 Be a Better Year for Biotech Than 2021? 3 Big Picks

Yahoo

01/19 10:27

Regeneron Says US FDA Accepts for Review its Supplemental BLA for Libtayo in Combination With Chemotherapy

MT Newswires

01/19 07:53

FDA Accepts for Review Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy for First-line Treatment of Advanced NSCLC

PR Newswire

01/19 07:00

Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patients in Phase 3 Trial

MT Newswires

01/19 03:59

Second Positive Phase 3 Dupixent® (dupilumab) Trial Confirms Significant Improvements for Patients with Prurigo Nodularis

Yahoo

01/19 00:59

Pendal Group Ltd Buys NXP Semiconductors NV, Ferguson PLC, Unilever PLC, Sells Philip Morris ...

Yahoo

01/18 13:38

Newman Dignan & Sheerar, Inc. Buys iShares Core MSCI Emerging Markets ETF, Applied Finance ...

Yahoo

01/18 13:38

Morgan Stanley Adjusts Regeneron Pharmaceuticals Price Target to $585 From $617, Maintains Equal Weight Rating

MT Newswires

01/18 13:01

5 ROE Stocks to Buy as Q4 Earnings Witness Shaky Start

Yahoo

01/18 09:10

Pfizer's (PFE) Cibinqo Gets FDA Nod for Atopic Dermatitis

Yahoo

01/17 09:20

2 Top Biotech Stocks to Buy and Hold for 10 Years

Yahoo

01/17 06:00

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Yahoo

01/14 12:10

Glaxo (GSK), Vir Seek EUA for Intramuscular Sotrovimab in US

Yahoo

01/14 10:30

Bausch (BHC) Eye Care Business Files for IPO in the US & Canada

Yahoo

01/14 10:16

Regeneron purchases more office space near East Greenbush factories

Yahoo

01/13 17:36

Regeneron to Report Fourth Quarter and Full Year 2021 Financial and Operating Results and Host Conference Call and Webcast on

PR Newswire

01/13 16:05

Pfizer's (PFE) Prevnar 20 Plus COVID Vaccine Study Succeeds

Yahoo

01/13 10:25

1 Key Ratio All Investors Should Be Looking at When Buying Growth Stocks in 2022

Yahoo

01/13 08:30

Fresh off CRISPR milestone, Intellia lays out 2022 vision

Yahoo

01/13 06:03

Vir extends gains as Needham lifts sales outlook for COVID-19 antibody therapy

SA Breaking News

01/12 15:20

Vertex (VRTX) Kaftrio Gets Europe Nod for CF in Children

Yahoo

01/12 10:42

Glaxo (GSK) & Vir to Supply More COVID Antibody Doses in US

Yahoo

01/12 09:48

BioCryst (BCRX) Stock Up on Q4 Orladeyo Preliminary Sales

Yahoo

01/11 11:13

Allogene (ALLO) Clinical Hold on CAR-T Studies Removed by FDA

Yahoo

01/11 11:11

Regeneron sees Q4 EYLEA U.S. sales of $1.54B, REGEN-COV sales of $2.29B

SA Breaking News

01/11 10:24

Moderna (MRNA) Up on Plans to Get Omicron Booster Ready in 2022

Yahoo

01/11 10:24

Omicron-specific vaccines are ‘already priced into COVID stocks’: Jefferies Managing Director

Yahoo

01/11 10:04

Vir Stock Jumps as U.S. Buys 600,000 More Glaxo Covid Antibody Doses

Yahoo

01/11 09:02

Regeneron (REGN) Collaborates With Ultragenyx for Evkeeza

Yahoo

01/10 10:28

Amgen's (AMGN) KRAS Inhibitor Gets Nod for Lung Cancer in EU

Yahoo

01/10 10:19

Biden administration to ask Congress for more COVID funding - WaPo

SA Breaking News

01/07 13:17

Regeneron Pharmaceuticals, Ultragenyx Pharmaceutical Strike Commercialization Deal for Evkeeza Medicine

MT Newswires

01/07 07:39

Regeneron and Ultragenyx Collaborate to Commercialize Evkeeza® (evinacumab) Outside the United States

PR Newswire

01/07 07:00

Regeneron (REGN) Gains As Market Dips: What You Should Know

Yahoo

01/06 18:00

Intellia (NTLA) Inks Deal With Kyverna for Autoimmune Diseases

Yahoo

01/06 13:43

Pfizer Upgraded by BofA; Regeneron, Amgen Downgraded

Yahoo

01/05 11:27

Regeneron downgraded to underperform at BofA on minimal COVID contribution in 2022

SA Breaking News

01/05 10:34

BofA Securities Downgrades Regeneron Pharmaceuticals to Underperform From Neutral

MT Newswires

01/05 09:20

Top Healthcare Stocks for January 2022

Yahoo

01/03 15:43

Bernstein Upgrades Regeneron Pharmaceuticals to Outperform From Market Perform; Price Target is $660

MT Newswires

01/03 06:23

Intellia's (NTLA) CRISPR Therapies Show Promise Amid Competition

Yahoo

12/31 11:40

Regeneron (REGN) Dips More Than Broader Markets: What You Should Know

Yahoo

12/30 17:45